April 30, 2021
RegMed Investors’ (RMi) pre-open: last trading session of April
April 29, 2021
RegMed Investors’ (RMi) pre-open: expectation and upcoming reactions
April 28, 2021
RegMed Investors’ (RMi) pre-open: running the liquidity relay, who will the cash pass to
April 27, 2021
RegMed Investors’ (RMi) pre-open: share pricing is volatile with low volumes
April 26, 2021
RegMed Investors’ (RMi) pre-open: a busy week is ahead
April 23, 2021
RegMed Investors’ (RMi) pre-open: TGIF, what will be sustainable in the cell and gene therapy habitat
April 22, 2021
RegMed Investors’ (RMi) pre-open: volatility evaporates, increases or decreases the upside
April 21, 2021
RegMed Investors’ (RMi) pre-open: what’s resonating?
April 20, 2021
RegMed Investors’ (RMi) pre-open: a few oversold should break the surface
April 19, 2021
RegMed Investors’ (RMi) pre-open: a dine and a dash scenario
April 16, 2021
RegMed Investors’ (RMi) pre-open: indications set some expectations
April 15, 2021
RegMed Investors’ (RMi) pre-open: fairly valued or subject to electronic trading selling any new highs
April 14, 2021
RegMed Investors’ (RMi) pre-open: are we investing or gambling
April 13, 2021
RegMed Investors’ (RMi) pre-open: trade or experience more meltdowns
April 12, 2021
RegMed Investors’ (RMi) pre-open: caution is in the air as the trend indicator beguiles
April 9, 2021
RegMed Investors’ (RMi) pre-open: trust, confidence versus conviction
April 8, 2021
RegMed Investors’ (RMi) pre-open: how now brown cow?
April 7, 2021
RegMed Investors’ (RMi) pre-open: share pricing exhibits a streaking on the field anticipating a tackling
April 6, 2021
RegMed Investors’ (RMi) pre-open: what’s normal in this market?
April 5, 2021
RegMed Investors’ (RMi) pre-open: what and where will the demand for increased share pricing come from?
April 1, 2021
RegMed Investors’ (RMi) pre-open: Q2 begins as holiday closes in
March 31, 2021
RegMed Investors’ (RMi) pre-open: a mixed bag, strength is a mixed bag to sell into
March 30, 2021
RegMed Investors’ (RMi) pre-open: countdown – 2 sessions and the month/quarter closes
March 29, 2021
RegMed Investors’ (RMi) pre-open: deal after reshuffling the deck with two (2) sessions left in month and quarter
March 26, 2021
RegMed Investors’ (RMi) pre-open: TGIF, strength is migratory and the cell and gene therapy sector seems directionless
6 hours 5 min ago
RMi pre-open: Cry or
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.